TrialJournal of neurology2013
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study.
Amit Bar-Or et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this paperpooled ittrialcites it